CLINICAL TRIALS PROFILE FOR TAVILERMIDE
✉ Email this page to a colleague
Clinical Trials for Tavilermide
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT01960010 ↗ | A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye | Completed | Mimetogen Pharmaceuticals USA, Inc. | Phase 3 | The purpose of this study is to assess the safety and efficacy of MIM-D3 Ophthalmic Solution compared with Placebo Ophthalmic Solution in treating the signs and symptoms of dry eye. |
| NCT02634853 ↗ | A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye | Completed | Mimetogen Pharmaceuticals USA, Inc. | Phase 3 | The purpose of this study is to assess the safety and efficacy of Tavilermide Ophthalmic Solution compared with Placebo Ophthalmic Solution in treating the signs and symptoms of dry eye. |
| NCT02665234 ↗ | A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease | Completed | Mimetogen Pharmaceuticals USA, Inc. | Phase 3 | The purpose of this study is to assess the safety and efficacy of Tavilermide Ophthalmic Solution compared with Placebo Ophthalmic Solution in treating the signs and symptoms of dry eye disease. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Tavilermide
Condition Name
Clinical Trial Locations for Tavilermide
Trials by Country
Clinical Trial Progress for Tavilermide
Clinical Trial Phase
Clinical Trial Sponsors for Tavilermide
Sponsor Name
